i2 Pharmaceuticals Appoints Chief Business Officerfeatured

Boulder CO – April 25, 2017 – i2 Pharmaceuticals, Inc., a biopharmaceutical company focused on next generation discovery and development of therapeutics with a focus on personalized cancer treatment, announced that Mark F. Kubik has joined the company in the role of Chief Business Officer effective February 1, 2017. Mr. Kubik will report to Dr. Read more